BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3349865)

  • 1. [Simplification of surgical technics for venous catheterization in isolated cytostatic drug perfusion of the upper extremity].
    Manner M; Göhring U; Schlag P
    Chirurg; 1988 Jan; 59(1):41-2. PubMed ID: 3349865
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dye concentration measurements for the determination of leakage during and following normothermic cytostatic perfusion in the treatment of tumors of the extremities].
    Krauss J; Lange U; Pauer HD; Krauss I
    Z Exp Chir Transplant Kunstliche Organe; 1984; 17(5):269-74. PubMed ID: 6095550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperthermic isolation perfusion of the extremities in malignant melanomas and soft tissue sarcomas].
    Tonak J; Hohenberger W; Göhl J
    Chirurg; 1984 Aug; 55(8):499-504. PubMed ID: 6488994
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolated limb perfusion: the European experience.
    Lejeune FJ; Kroon BB; Di Filippo F; Hoekstra HJ; Santinami M; Liénard D; Eggermont AM
    Surg Oncol Clin N Am; 2001 Oct; 10(4):821-32, ix. PubMed ID: 11641093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated limb perfusion: what is the evidence for its use?
    Noorda EM; Vrouenraets BC; Nieweg OE; Van Coevorden F; Kroon BB
    Ann Surg Oncol; 2004 Sep; 11(9):837-45. PubMed ID: 15313738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regional hyperthermic cytostatic perfusion as an alternative in the treatment of malignant soft tissue tumors of the extremities].
    Ghussen F; Nagel K
    Chirurg; 1984 Aug; 55(8):505-7. PubMed ID: 6488995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolated hyperthermic extremity perfusion in soft tissue sarcoma].
    Eigler FW; Krause U
    Chirurg; 1997 Jun; 68(6):649. PubMed ID: 9324449
    [No Abstract]   [Full Text] [Related]  

  • 9. [New modifications in isolated extremity perfusion ].
    Aigner K; Hild P; Hundeiker M
    Z Hautkr; 1982 Jul; 57(14):1044-54. PubMed ID: 6889794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives.
    Eggermont AM
    Anticancer Res; 1998; 18(5D):3899-905. PubMed ID: 9854502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
    Sutherland CM; Mather FJ; Krementz ET
    Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Soft tissue sarcoma: isolated hyperthermic extremity perfusion. Technique and indications].
    Schlag PM; Kettelhack C
    Chirurg; 1993 Jun; 64(6):455-60. PubMed ID: 8359057
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical chemotherapy in the management of melanoblastoma of the lower extremities.
    Rahóty P; Besznyák I; Erdélyi-Tóth V; Sulvok Z; Péley G
    Acta Chir Hung; 1997; 36(1-4):282-3. PubMed ID: 9408375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-based isolated limb perfusion in unresectable extremity desmoid tumours.
    Grünhagen DJ; de Wilt JH; Verhoef C; van Geel AN; Eggermont AM
    Eur J Surg Oncol; 2005 Oct; 31(8):912-6. PubMed ID: 16098709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional isolated perfusion of high risk melanoma of the extremities with imidazole carboxamide.
    Ariyan S; Mitchell MS; Kirkwood JM
    Surg Gynecol Obstet; 1984 Mar; 158(3):238-42. PubMed ID: 6701736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolated infusion effective in melanoma and sarcoma. Good alternative for regional isolated cytostatic perfusion].
    Kroon HM; Thompson JF; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2009 Mar; 153(11):508-14. PubMed ID: 19402327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Isolated extremity perfusion with TNF-alpha and melphalan in unresectable soft tissue sarcoma. Indications, principles and technique].
    Taeger G; Ruchholtz S; Niebel W; Müller S; Nast-Kolb D
    Unfallchirurg; 2004 Jul; 107(7):619-23. PubMed ID: 15252711
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperthermia and chemotherapy by regional perfusion for tumors of the extremities.
    Cavaliere R; Di Filippo F; Moricca G; Santori F; Varanese A; Cavallari A; Carlini S; Brunori M; Aloe L; Monticelli G
    Prog Clin Biol Res; 1982; 107():775-92. PubMed ID: 6962956
    [No Abstract]   [Full Text] [Related]  

  • 19. Alteration of tissue oxygen partial pressure during isolated, hyperthermic limb perfusion with cytostatic drugs or recombinant human tumor necrosis factor alpha combined with melphalan.
    Hohenberger P; Bida B; Schlag PM
    Strahlenther Onkol; 1996 Nov; 172 Suppl 2():14-5. PubMed ID: 8946039
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolated limb perfusion in regional melanoma.
    Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
    Surg Oncol Clin N Am; 2006 Apr; 15(2):373-84. PubMed ID: 16632221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.